Shopping Cart 0
Cart Subtotal
AED 0

Merz Pharma GmbH & Co KgaA - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Merz Pharma GmbH & Co KgaA (Merz Pharma) is an aesthetics and neurotoxin company that develops products for aesthetic and medical dermatology and neurological movement disorders. The company's products include aesthetics, ethical drugs, over-the-counter drugs, neurology, and central nervous system, skin and hair care, vitamins and minerals, and dental devices. It offers products for various therapeutic areas such as Alzheimer's disease, depression, dystonia, hair loss, liver diseases, Parkinson's disease, cold, scars, wrinkles and other skin disorders. The company also offers vitamins and minerals, and hygienic products for medical disinfection and cleaning. It operates in Australia, Switzerland, Spain, France, the US and the UK, among others. Merz Pharma is headquartered in Frankfurt am Main, Germany.

Merz Pharma GmbH & Co KgaA-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Merz Pharma GmbH & Co KgaA, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deal Details 10

Venture Financing 10

Cytrellis Biosystems Raises USD28.5 Million in Series B Financing 10

Cytrellis Biosystems Raises Funds through Venture Financing 11

Cabochon Aesthetics Raises USD0.4 Million In Venture Financing 12

Partnerships 13

Merz Pharma Enters into Distribution Agreement with Ulthera 13

Equity Offering 14

Ulthera Withdraws IPO 14

Acquisition 15

Merz North America Acquires ON Light Sciences 15

Shofu to Acquire Merz Dental from Merz Pharma for USD19 Million 16

Merz Pharma Completes Acquisition of Ulthera for USD600 Million 17

Ulthera Acquires Cabochon Aesthetics, Minimally Invasive Treatments Provider 18

Merz Pharma Acquires Anteis, Aesthetics Company 19

Merz Pharma Acquires Neocutis, Dermatology Company 20

Merz Pharma GmbH & Co KgaA-Key Competitors 21

Merz Pharma GmbH & Co KgaA-Key Employees 22

Merz Pharma GmbH & Co KgaA-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 25

Corporate Communications 25

Apr 04, 2017: Merz Appoints Bob Rhatigan as President and Chief Executive Officer in North America 25

Product News 26

May 18, 2017: Merz Celebrates a Monumental Milestone: One Million Treatments Worldwide With Ultherapy 26

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Merz Pharma GmbH & Co KgaA, Medical Equipment, Key Facts 2

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Merz Pharma GmbH & Co KgaA, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Merz Pharma GmbH & Co KgaA, Deals By Market, 2012 to YTD 2018 8

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Cytrellis Biosystems Raises USD28.5 Million in Series B Financing 10

Cytrellis Biosystems Raises Funds through Venture Financing 11

Cabochon Aesthetics Raises USD0.4 Million In Venture Financing 12

Merz Pharma Enters into Distribution Agreement with Ulthera 13

Ulthera Withdraws IPO 14

Merz North America Acquires ON Light Sciences 15

Shofu to Acquire Merz Dental from Merz Pharma for USD19 Million 16

Merz Pharma Completes Acquisition of Ulthera for USD600 Million 17

Ulthera Acquires Cabochon Aesthetics, Minimally Invasive Treatments Provider 18

Merz Pharma Acquires Anteis, Aesthetics Company 19

Merz Pharma Acquires Neocutis, Dermatology Company 20

Merz Pharma GmbH & Co KgaA, Key Competitors 21

Merz Pharma GmbH & Co KgaA, Key Employees 22

Merz Pharma GmbH & Co KgaA, Other Locations 23

Merz Pharma GmbH & Co KgaA, Subsidiaries 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Merz Pharma GmbH & Co KgaA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Merz Pharma GmbH & Co KgaA (Merz Pharma) is an aesthetics and neurotoxin company that develops products for aesthetic and medical dermatology and neurological movement disorders. The company's products include aesthetics, ethical drugs, over-the-counter drugs, neurology, and central nervous system, skin and hair care, vitamins and minerals, and dental devices. It offers products for various therapeutic areas such as Alzheimer's disease, depression, dystonia, hair loss, liver diseases, Parkinson's disease, cold, scars, wrinkles and other skin disorders. The company also offers vitamins and minerals, and hygienic products for medical disinfection and cleaning. It operates in Australia, Switzerland, Spain, France, the US and the UK, among others. Merz Pharma is headquartered in Frankfurt am Main, Germany.

Merz Pharma GmbH & Co KgaA-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Merz Pharma GmbH & Co KgaA, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deal Details 10

Venture Financing 10

Cytrellis Biosystems Raises USD28.5 Million in Series B Financing 10

Cytrellis Biosystems Raises Funds through Venture Financing 11

Cabochon Aesthetics Raises USD0.4 Million In Venture Financing 12

Partnerships 13

Merz Pharma Enters into Distribution Agreement with Ulthera 13

Equity Offering 14

Ulthera Withdraws IPO 14

Acquisition 15

Merz North America Acquires ON Light Sciences 15

Shofu to Acquire Merz Dental from Merz Pharma for USD19 Million 16

Merz Pharma Completes Acquisition of Ulthera for USD600 Million 17

Ulthera Acquires Cabochon Aesthetics, Minimally Invasive Treatments Provider 18

Merz Pharma Acquires Anteis, Aesthetics Company 19

Merz Pharma Acquires Neocutis, Dermatology Company 20

Merz Pharma GmbH & Co KgaA-Key Competitors 21

Merz Pharma GmbH & Co KgaA-Key Employees 22

Merz Pharma GmbH & Co KgaA-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 25

Corporate Communications 25

Apr 04, 2017: Merz Appoints Bob Rhatigan as President and Chief Executive Officer in North America 25

Product News 26

May 18, 2017: Merz Celebrates a Monumental Milestone: One Million Treatments Worldwide With Ultherapy 26

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Merz Pharma GmbH & Co KgaA, Medical Equipment, Key Facts 2

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Merz Pharma GmbH & Co KgaA, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Merz Pharma GmbH & Co KgaA, Deals By Market, 2012 to YTD 2018 8

Merz Pharma GmbH & Co KgaA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Cytrellis Biosystems Raises USD28.5 Million in Series B Financing 10

Cytrellis Biosystems Raises Funds through Venture Financing 11

Cabochon Aesthetics Raises USD0.4 Million In Venture Financing 12

Merz Pharma Enters into Distribution Agreement with Ulthera 13

Ulthera Withdraws IPO 14

Merz North America Acquires ON Light Sciences 15

Shofu to Acquire Merz Dental from Merz Pharma for USD19 Million 16

Merz Pharma Completes Acquisition of Ulthera for USD600 Million 17

Ulthera Acquires Cabochon Aesthetics, Minimally Invasive Treatments Provider 18

Merz Pharma Acquires Anteis, Aesthetics Company 19

Merz Pharma Acquires Neocutis, Dermatology Company 20

Merz Pharma GmbH & Co KgaA, Key Competitors 21

Merz Pharma GmbH & Co KgaA, Key Employees 22

Merz Pharma GmbH & Co KgaA, Other Locations 23

Merz Pharma GmbH & Co KgaA, Subsidiaries 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Merz Pharma GmbH & Co KgaA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.